Helene Dutartre

Title: Helene Dutartre: Innovator in Hepatitis C Immunization

Introduction

Helene Dutartre is a prominent inventor based in Dallas, TX (US), known for her significant contributions to the field of immunology. She has developed innovative methods and compositions aimed at immunizing against the hepatitis C virus (HCV). Her work has the potential to impact the treatment and prevention of this viral infection in human subjects.

Latest Patents

Helene Dutartre holds a patent for "Compositions and methods to immunize against hepatitis C virus." This patent describes compositions comprising viral antigens and antigenic peptides derived from HCV proteins, which are fused to antibodies specific for dendritic cells. The patent outlines immunostimulatory compositions, including HCV vaccines and methods for enhancing the effectiveness of HCV antigen presentation by antigen-presenting cells. These methods aim to provide treatment, prophylaxis, or a combination thereof against hepatitis C, as well as methods for immunostimulation through the activation of dendritic cells.

Career Highlights

Throughout her career, Helene has worked with esteemed institutions such as Baylor Research Institute and the Institut National de la Santé et de la Recherche Médicale. Her research has focused on developing effective strategies for combating hepatitis C, showcasing her dedication to advancing medical science.

Collaborations

Helene has collaborated with notable professionals in her field, including Yves Levy and Jacques F. Banchereau. These collaborations have contributed to her innovative research and the development of her patented technologies.

Conclusion

Helene Dutartre's work in immunology, particularly her patent related to hepatitis C, highlights her role as a key innovator in the field. Her contributions have the potential to significantly improve the prevention and treatment of hepatitis C, showcasing the importance of innovation in medical research.